Industry Profile
Metabolic Disorders Therapeutics
Target researchers — Metabolic biologists, endocrinologists, and pharmacologists specializing in GLP-1 biology, insulin signaling, adipose tissue metabolism, gut hormone interactions, NASH pathophysiology, and metabolic syndrome animal models
Metabolic disorder companies develop drugs for type 2 diabetes, obesity, NASH, and dyslipidemia, with GLP-1 receptor agonists currently driving record revenues. Academic metabolic research groups at medical schools provide the mechanistic insights, mouse models, and biomarker pipelines that fuel the next generation of metabolic targets.
Key Companies
Use Cases
GLP-1 receptor agonist co-development
NASH biomarker partnerships
Adipose biology target licensing
Diabetes animal model access
Metabolomics profiling services
Gut hormone peptide chemistry consulting
Free to browse · subscribe to unlock the full dataset
See the full dataset.
Create a free account to search every researcher, set alerts, and export verified contacts to CSV / API.
Sign Up Free →